CTA056 是一种ITK(IL-2 诱导型 T 细胞激酶)抑制剂，其IC50为 0.1 μM。CTA056 选择性靶向恶性 T 细胞并调节肿瘤抑制因子。CTA056 诱导细胞凋亡，是治疗 T 细胞白血病和淋巴瘤的潜在药物。
| 生物活性 | CTA056 is anITK(IL-2-inducible T-cell kinase) inhibitor with anIC50of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 inducesapoptosisand is a potential therapeutic agent for the treatment of T-cell leukemia and lymphoma[1]. |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
